Together with adopting a healthy lifestyle, Medicines are important pillar in
keeping healthy or getting our health back if we may have been ill. However, we
often know very little about the medicines we use. This section is a guide to the
numerous medicines that are registered in Kenya.
We appreciate your feedback! [Last updated Dec:2011]
Displaying 6241-6250 of 12466 results.
Product Name | Dosage Form | Active Ingredients | Manufacturer Name | Class | |
---|---|---|---|---|---|
FERIZEST CAPSULES | CAPSULES | Carbonyl Iron equivalent to elemental Iron 60 mg; Folic Acid BP 1.5 mg; Vitamin B12 BP 15 mcg; Vitamin C BP 75 mg; Zinc Sulphate Monohydrate USP 10 mg | DWD PHARMACEUTICALS LTD; INDIA | BLOOD, DRUGS AFFECTING | Report Effects |
COSKLOT 250 MG TABLETS | TABLETS | ETAMSYLATE BP 250 MG | COSME PHARMA LTD | BLOOD, DRUGS AFFECTING | Report Effects |
COSKLOT 500MG TABLETS | TABLETS | ETAMSYLATE BP 500 MG | COSME PHARMA LTD | BLOOD, DRUGS AFFECTING | Report Effects |
COSKLOT INJECTION (2ML) | INJECTION | ETAMSYLATE BP 250 MG | COSME PHARMA LTD | BLOOD, DRUGS AFFECTING | Report Effects |
JECTOCOS INJECTION (1.5ML) | INJECTION | IRON SORBITOL CITRIC ACID COMPLEX CORRESPONDING TOTAL IRON 50 MG | COSME PHARMA LTD | BLOOD, DRUGS AFFECTING | Report Effects |
ENCIFER IV INJECTION | INJECTION | FERRIC HYDROXIDE IN COMPLEX WITH SUCROSE EQUIVALENT TO ELEMENTAL IRON 100 MG | EMCURE PHARMACEUTICALS LIMITED; INDIA | BLOOD, DRUGS AFFECTING | Report Effects |
TX ? 500 INJECTION | INJECTION | TRANEXAMIC ACID BP 500 MG | OCHOA LABORATORIES | BLOOD, DRUGS AFFECTING | Report Effects |
DICYNONE 250MG INJECTION | INJECTION | ETAMSYLATE (INN) 250 MG/PER AMPOULE | OM PHARMA; SWITZERLAND | BLOOD, DRUGS AFFECTING | Report Effects |
ANTIPLATT TABLETS | TABLETS | CLOPIDOGREL BISULFATE USP EQUIVALENT TO CLOPIDOGREL 75 MG | TROIKAA PHARMACEUTICALS | BLOOD, DRUGS AFFECTING | Report Effects |
HIFER SUSPENSION | SUSPENSION | ACTIVE INGREDIENTS PER 5 ML: ELEMENTAL IRON 50 MG; CYANOCOBALAMIN IP 6 MCG | ZEST PHARMA LTD; INDIA | BLOOD, DRUGS AFFECTING | Report Effects |